ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,894Medicare Part D Prescriptions Filled, Including Refills

Rank: 309 out of 1844

$554K Total Retail Price of All Prescriptions

Rank: 278 out of 1844

496 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 496 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 7,493 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 336 199 S3 1 2
LEVOTHYROXINE SODIUM 315 280 2 1
AMLODIPINE BESYLATE 301 280 3 6
METFORMIN HCL 256 241 4 8
METOPROLOL SUCCINATE 231 214 5 14
LOSARTAN-HYDROCHLOROTHIAZIDE 213 176 6 47
SIMVASTATIN 209 199 7 3
OMEPRAZOLE 194 176 8 5
LOSARTAN POTASSIUM 182 177 9 24
GABAPENTIN 171 139 10 15
METOPROLOL TARTRATE 170 152 11 11
TRAMADOL HCL 154 146 12 18
SYNTHROID 147 135 13 55
FUROSEMIDE 143 120 14 7
TAMSULOSIN HCL 129 115 15 27
LISINOPRIL 123 103 16 4
ZOLPIDEM TARTRATE 119 105 17 23
HYDROCHLOROTHIAZIDE 115 75 18 9
FLUOXETINE HCL 114 101 19 41
FLUTICASONE PROPIONATE 108 99 20 50
MELOXICAM 106 98 21 28
ATORVASTATIN CALCIUM 102 84 22 12
CITALOPRAM HBR 95 77 23 19
DONEPEZIL HCL 95 94 23 26
CYMBALTA 92 72 25 36
PRAVASTATIN SODIUM 87 78 26 10
AMOXICILLIN 85 75 27 101
SPIRONOLACTONE 84 61 28 60
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 45 29 20
SPIRIVA 79 67 30 57
SERTRALINE HCL 77 48 31 21
CELEBREX 76 73 32 91
ALLOPURINOL 74 73 33 29
CLONIDINE HCL 74 70 33 64
PREDNISONE 74 70 33 40
NAMENDA 69 69 36 33
TRIAMCINOLONE ACETONIDE 67 47 37 153
CIPROFLOXACIN HCL 64 52 38 62
BENAZEPRIL-HYDROCHLOROTHIAZIDE 64 54 38 225
POTASSIUM CHLORIDE 61 54 40 16
MECLIZINE HCL 60 59 41 142
NAPROXEN 59 55 42 87
BENAZEPRIL HCL 58 53 43 75
CLOPIDOGREL 57 47 44 34
LYRICA 57 24 44 92
DIOVAN HCT 55 55 46 96
ALENDRONATE SODIUM 54 51 47 25
DOXYCYCLINE HYCLATE 54 45 47 90
WARFARIN SODIUM 50 50 49 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.